Masoom Yasinzai

Islamabad, IS, Pakistan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Impact of an indigenously produced multi-enzyme complex from Bacillus subtilis KT004404 on growth and blood parameters in broiler chicken.

Impact of an indigenously produced multi-enzyme complex from Bacillus subtilis KT004404 on growth and blood parameters in broiler chicken.

Journal: PloS one

Published: February 09, 2022

Novel coumarin-isatin hybrids as potent antileishmanial agents: Synthesis, in silico and in vitro evaluations.

Novel coumarin-isatin hybrids as potent antileishmanial agents: Synthesis, in silico and in vitro evaluations.

Journal: Bioorganic chemistry

Published: January 16, 2021

Reactive oxygen species generating photosynthesized ferromagnetic iron oxide nanorods as promising antileishmanial agent.

Reactive oxygen species generating photosynthesized ferromagnetic iron oxide nanorods as promising antileishmanial agent.

Journal: Nanomedicine (London, England)

Published: March 21, 2020

Isolation and Characterization of Leishmanial Adenine Aminohydrolase as a Drug Target.

Isolation and Characterization of Leishmanial Adenine Aminohydrolase as a Drug Target.

Journal: Current computer-aided drug design

Published: March 04, 2020

Synthesis and computational studies of highly selective inhibitors of human recombinant tissue non-specific alkaline phosphatase (h-TNAP): A therapeutic target against vascular calcification.

Synthesis and computational studies of highly selective inhibitors of human recombinant tissue non-specific alkaline phosphatase (h-TNAP): A therapeutic target against vascular calcification.

Journal: Bioorganic chemistry

Published: February 12, 2020

Self-Nanoemulsifying Drug Delivery System (SNEDDS) for Improved Oral Bioavailability of Chlorpromazine: In Vitro and In Vivo Evaluation.

Self-Nanoemulsifying Drug Delivery System (SNEDDS) for Improved Oral Bioavailability of Chlorpromazine: In Vitro and In Vivo Evaluation.

Journal: Medicina (Kaunas, Lithuania)

Published: March 08, 2019

Mannosylated thiolated paromomycin-loaded PLGA nanoparticles for the oral therapy of visceral leishmaniasis.

Mannosylated thiolated paromomycin-loaded PLGA nanoparticles for the oral therapy of visceral leishmaniasis.

Journal: Nanomedicine (London, England)

Published: January 29, 2019

Design of mannosylated oral amphotericin B nanoformulation: efficacy and safety in visceral leishmaniasis.

Design of mannosylated oral amphotericin B nanoformulation: efficacy and safety in visceral leishmaniasis.

Journal: Artificial cells, nanomedicine, and biotechnology

Published: February 02, 2018

Mannosylated thiolated polyethylenimine nanoparticles for the enhanced efficacy of antimonial drug against Leishmaniasis.

Mannosylated thiolated polyethylenimine nanoparticles for the enhanced efficacy of antimonial drug against Leishmaniasis.

Journal: Nanomedicine (London, England)

Published: November 28, 2017

Redox biology of Leishmania and macrophage targeted nanoparticles for therapy.

Redox biology of Leishmania and macrophage targeted nanoparticles for therapy.

Journal: Nanomedicine (London, England)

Published: June 22, 2017

Development of mannose-anchored thiolated amphotericin B nanocarriers for treatment of visceral leishmaniasis.

Development of mannose-anchored thiolated amphotericin B nanocarriers for treatment of visceral leishmaniasis.

Journal: Nanomedicine (London, England)

Published: November 24, 2016

Annihilation of Leishmania by daylight responsive ZnO nanoparticles: a temporal relationship of reactive oxygen species-induced lipid and protein oxidation.

Annihilation of Leishmania by daylight responsive ZnO nanoparticles: a temporal relationship of reactive oxygen species-induced lipid and protein oxidation.

Journal: International journal of nanomedicine

Published: June 23, 2016

Showing 1-12 of 23

Last Updated: 09/26/2026